Phase IB Dose-Escalation Study of the Akt Inhibitor Gdc-0068 with Docetaxel (D) or Modified Folfox6 (F) in Patients (PTS) with Advanced Solid Tumors
Bendell, J., Roda, D., Mateo, J., Hollebecque, A., De Mattos-Arruda, L., Meng, R., Isakoff, S., Molife, L.R., Tabernero, J., Ruiperez, A. CervantesVolume:
23
Journal:
Annals of Oncology
DOI:
10.1016/s0923-7534(20)33017-9
Date:
September, 2012
File:
PDF, 63 KB
2012